Status:
COMPLETED
Pattern Recognition Prosthetic Control
Lead Sponsor:
Coapt, LLC
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Prosthesis User
Congenital Amputation of Upper Limb
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study investigates whether simultaneous electromyographic (EMG)-based pattern recognition control of an upper limb prostheses increases wear time among users. In contrast to conventional, seamles...
Eligibility Criteria
Inclusion
- Subjects have an upper-limb difference (congenital or acquired) at the transradial (between the wrist and elbow), elbow disarticulation (at the elbow), transhumeral (between the elbow and shoulder), or shoulder disarticulation (at the shoulder) level.
- Subjects are suitable to be, or already are, a Coapt pattern recognition user (Coapt Complete Control Gen2 device).
- Subjects are between the ages of 18 and 70.
Exclusion
- Subjects with significant cognitive deficits or visual impairment that would preclude them from giving informed consent or following instructions during the experiments, or the ability to obtain relevant user feedback discussion.
- Subjects who are non-English speaking.
- Subjects who are pregnant.
Key Trial Info
Start Date :
November 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 18 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04272593
Start Date
November 16 2020
End Date
July 18 2022
Last Update
October 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Coapt, LLC
Chicago, Illinois, United States, 60654